Law360, New York (October 25, 2012, 12:00 AM ET) -- Patents held by multinational pharmaceutical companies are under assault in the developing world. Novartis is mired in a years-long case seeking to patent one of its drugs in India, and it is now challenging before the Supreme Court of India a provision of the Indian Patents Act that Novartis says violates international law.[1]
Also, Roche recently lost a major patent infringement case in India's courts, thereby allowing a massive generic manufacturer headquartered in India to continue marketing a generic version of Roche's cancer-treatment drug.[2] And Pfizer...
A Growing Problem For Multinational Pharmas
To view the full article, take a free trial now.
